CTI BioPharma
CTIC
#5627
Rank
HK$9.33 B
Marketcap
HK$70.76
Share price
0.00%
Change (1 day)
30.80%
Change (1 year)

CTI BioPharma (CTIC) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : HK$1.07 Billion

According to CTI BioPharma 's latest financial reports the company's total liabilities are HK$1.07 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CTI BioPharma - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31HK$1.12 B109.4%
2021-12-31HK$0.53 B279.25%
2020-12-31HK$0.14 B-36.06%
2019-12-31HK$0.22 B-23.58%
2018-12-31HK$0.28 B-4.69%
2017-12-31HK$0.30 B-30.31%
2016-12-31HK$0.43 B-42.1%
2015-12-31HK$0.75 B79.98%
2014-12-31HK$0.41 B5.61%
2013-12-31HK$0.39 B25.06%
2012-12-31HK$0.31 B18.86%
2011-12-31HK$0.26 B-41.84%
2010-12-31HK$0.45 B-33.28%
2009-12-31HK$0.68 B-52.81%
2008-12-31HK$1.45 B2.66%
2007-12-31HK$1.41 B-10.6%
2006-12-31HK$1.58 B-22.27%
2005-12-31HK$2.03 B2.44%
2004-12-31HK$1.98 B12.13%
2003-12-31HK$1.77 B58.58%
2002-12-31HK$1.11 B-26.2%
2001-12-31HK$1.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
HK$626.83 B 58,410.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$609.45 B 56,788.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
HK$13.07 B 1,120.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
HK$107.84 B 9,966.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$709.06 B 66,086.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$253.79 B 23,590.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$486.83 B 45,342.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland